JP2017512838A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017512838A5 JP2017512838A5 JP2017502946A JP2017502946A JP2017512838A5 JP 2017512838 A5 JP2017512838 A5 JP 2017512838A5 JP 2017502946 A JP2017502946 A JP 2017502946A JP 2017502946 A JP2017502946 A JP 2017502946A JP 2017512838 A5 JP2017512838 A5 JP 2017512838A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- seq
- antibody
- isolated antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2014/074199 | 2014-03-27 | ||
| CN2014074199 | 2014-03-27 | ||
| CN2014081797 | 2014-07-08 | ||
| CNPCT/CN2014/081797 | 2014-07-08 | ||
| PCT/US2015/023108 WO2015148984A2 (en) | 2014-03-27 | 2015-03-27 | Antibodies that bind human cannabinoid 1 (cb1) receptor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017512838A JP2017512838A (ja) | 2017-05-25 |
| JP2017512838A5 true JP2017512838A5 (show.php) | 2018-05-17 |
| JP6598844B2 JP6598844B2 (ja) | 2019-10-30 |
Family
ID=53008849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017502946A Active JP6598844B2 (ja) | 2014-03-27 | 2015-03-27 | ヒトカンナビノイド１（ｃｂ１）受容体に結合する抗体 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US10308712B2 (show.php) |
| EP (2) | EP3122780B1 (show.php) |
| JP (1) | JP6598844B2 (show.php) |
| KR (2) | KR102731863B1 (show.php) |
| CN (1) | CN106232626B (show.php) |
| AU (1) | AU2015237275B2 (show.php) |
| CA (1) | CA2944049A1 (show.php) |
| CL (3) | CL2016002433A1 (show.php) |
| ES (1) | ES2915101T3 (show.php) |
| IL (1) | IL248006B2 (show.php) |
| MA (1) | MA39708A (show.php) |
| MX (1) | MX2016012403A (show.php) |
| PE (1) | PE20170258A1 (show.php) |
| RU (1) | RU2730674C2 (show.php) |
| TW (1) | TWI694086B (show.php) |
| WO (1) | WO2015148984A2 (show.php) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3122780B1 (en) * | 2014-03-27 | 2022-03-09 | Bird Rock Bio, Inc. | Antibodies that bind human cannabinoid 1 (cb1) receptor |
| CN108513615B (zh) | 2015-09-30 | 2022-03-08 | 鸟石生物公司 | 结合人大麻素1(cb1)受体的抗体 |
| CN110997712B (zh) | 2017-06-05 | 2024-03-19 | 詹森生物科技公司 | 特异性结合pd-1的抗体及其使用方法 |
| CN110914430B (zh) * | 2017-07-13 | 2023-11-21 | 协和麒麟株式会社 | 抗bril抗体以及使用了该抗体的bril融合蛋白质的稳定化方法 |
| CN108588071A (zh) * | 2018-04-25 | 2018-09-28 | 和元生物技术（上海）股份有限公司 | CRISPR-Cas9靶向敲除人肠癌细胞CNR1基因及其特异性的sgRNA |
| CA3098416A1 (en) | 2018-04-30 | 2019-11-07 | Takeda Pharmaceutical Company Limited | Cannabinoid receptor type 1 (cb1) binding proteins and uses thereof |
| US20210267959A1 (en) * | 2018-07-17 | 2021-09-02 | The Regents Of The University Of California | Methods of treating renal disease |
| JP7597784B2 (ja) * | 2019-07-11 | 2024-12-10 | タヴォテック バイオセラピューティクス （ホン コン） リミテッド | 胸腺間質性リンパ球新生因子（ｔｓｌｐ）受容体シグナル伝達に干渉する薬剤 |
| JP2025512973A (ja) * | 2022-04-04 | 2025-04-22 | バード ロック バイオ サブ， インコーポレイテッド | 急速進行性腎臓病の予測および処置 |
| WO2023234406A1 (ja) | 2022-06-03 | 2023-12-07 | 塩野義製薬株式会社 | カンナビノイド１型受容体に結合する抗体 |
| CN119585311A (zh) * | 2022-07-28 | 2025-03-07 | 长春金赛药业有限责任公司 | 结合大麻素受体cb1的抗体及其用途 |
| WO2024212999A1 (zh) * | 2023-04-11 | 2024-10-17 | 微境生物医药科技(上海)有限公司 | Cbl-b抑制剂 |
| CN118027211A (zh) * | 2024-04-11 | 2024-05-14 | 上海惠盾因泰生物科技有限公司 | 一种识别重组egf-crm197疫苗的单克隆抗体及其应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466579A (en) | 1987-12-28 | 1995-11-14 | Psychemedics Corporation | Hair analysis method |
| US5460785A (en) | 1989-08-09 | 1995-10-24 | Rhomed Incorporated | Direct labeling of antibodies and other protein with metal ions |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| US5817766A (en) | 1995-04-05 | 1998-10-06 | Roche Diagnostic Systems, Inc. | Reagents for a cannabinoid immunoassay |
| US20020102208A1 (en) | 1999-03-01 | 2002-08-01 | Paul Chinn | Radiolabeling kit and binding assay |
| LT2857516T (lt) | 2000-04-11 | 2017-09-11 | Genentech, Inc. | Multivalentiniai antikūnai ir jų panaudojimas |
| US7214786B2 (en) | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| AU2003210060B2 (en) | 2002-03-22 | 2010-02-25 | Aprogen, Inc. | Humanized antibody and process for preparing same |
| EP1641493A4 (en) * | 2003-06-30 | 2007-10-31 | Merck & Co Inc | RADIOACTIVELY MARKED CANNABINOID-1 RECEPTOR MODULATORS |
| US20050095674A1 (en) | 2003-07-23 | 2005-05-05 | Lewis Deborah L. | Cannabinoid receptor interacting proteins and methods of use |
| WO2005023232A2 (en) | 2003-09-04 | 2005-03-17 | Affibody Ab | Therapeutic, screening and diagnostic methods based on the effect of cb1 receptor modulation on lymphoproliferative disorders. |
| EP1574211A1 (en) | 2004-03-09 | 2005-09-14 | Inserm | Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
| ITMI20041033A1 (it) * | 2004-05-24 | 2004-08-24 | Neuroscienze S C A R L | Composti farmaceutici |
| WO2006047417A2 (en) | 2004-10-21 | 2006-05-04 | University Of Florida Research Foundation, Inc. | Detection of cannabinoid receptor biomarkers and uses thereof |
| CA2609783A1 (en) * | 2005-05-27 | 2006-12-07 | Pfizer Products Inc. | Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| NZ597168A (en) | 2005-08-19 | 2013-07-26 | Abbott Lab | Dual variable domain immunoglobin and uses thereof |
| US7833260B2 (en) | 2006-07-20 | 2010-11-16 | Orbusneich Medical, Inc. | Bioabsorbable polymeric medical device |
| WO2008048648A2 (en) | 2006-10-17 | 2008-04-24 | Acadia Pharmaceuticals Inc. | Cb1-modulating compounds and their use |
| UA99620C2 (en) | 2007-05-23 | 2012-09-10 | Мерк Шарп Энд Доме Корп. | Pyridyl piperidine orexin receptor antagonists |
| WO2009136382A2 (en) | 2008-05-09 | 2009-11-12 | Abbott Gmbh & Co. Kg | Antibodies to receptor of advanced glycation end products (rage) and uses thereof |
| FI20085579A0 (fi) | 2008-06-12 | 2008-06-12 | Valtion Teknillinen | Kannabiskäytön toteaminen |
| IT1394400B1 (it) * | 2009-02-25 | 2012-06-15 | Neuroscienze Pharmaness S C Ar L | Composizioni farmaceutiche |
| ES2641612T3 (es) | 2009-04-17 | 2017-11-10 | Immunas Pharma, Inc. | Anticuerpos que se unen específicamente a oligómeros de beta A y uso de los mismos |
| ITTO20110641A1 (it) * | 2010-07-15 | 2012-01-16 | Oleg Iliich Epshtein | Composizioni farmaceutiche e metodi di trattamento |
| EP2655415A4 (en) | 2010-12-22 | 2016-03-09 | Abbvie Inc | THREE VARIABLE DOMAIN LINK PROTEINS AND USES THEREOF |
| US20120201746A1 (en) | 2010-12-22 | 2012-08-09 | Abbott Laboratories | Half immunoglobulin binding proteins and uses thereof |
| US9441033B2 (en) | 2011-02-14 | 2016-09-13 | Randox Laboratories Limited | Detection of synthetic cannabinoids |
| GB201102544D0 (en) | 2011-02-14 | 2011-03-30 | Randox Lab Ltd | Assay |
| US9435817B2 (en) | 2011-02-14 | 2016-09-06 | Randox Laboratories Limited | Detection of synthetic cannabinoids |
| DK3170501T3 (da) | 2011-05-20 | 2020-09-28 | Inst Nat Sante Rech Med | Antagonister af cb1-receptor |
| US8758826B2 (en) | 2011-07-05 | 2014-06-24 | Wet Inc. | Cannabinoid receptor binding agents, compositions, and methods |
| EP2698383B1 (en) | 2012-08-14 | 2020-11-25 | Randox Laboratories Ltd. | Detection of synthetic Cannabinoids |
| AU2014302410B2 (en) | 2013-06-26 | 2019-06-13 | Amgen Inc. | CB1 receptor antigen-binding proteins and uses thereof |
| CN106104273A (zh) | 2013-12-12 | 2016-11-09 | 施特姆森特克斯股份有限公司 | 新型抗dpep3抗体和使用方法 |
| EP3122780B1 (en) * | 2014-03-27 | 2022-03-09 | Bird Rock Bio, Inc. | Antibodies that bind human cannabinoid 1 (cb1) receptor |
-
2015
- 2015-03-27 EP EP15719033.1A patent/EP3122780B1/en active Active
- 2015-03-27 CN CN201580015645.5A patent/CN106232626B/zh active Active
- 2015-03-27 RU RU2016141919A patent/RU2730674C2/ru active
- 2015-03-27 ES ES15719033T patent/ES2915101T3/es active Active
- 2015-03-27 US US14/774,582 patent/US10308712B2/en active Active
- 2015-03-27 PE PE2016001719A patent/PE20170258A1/es unknown
- 2015-03-27 CA CA2944049A patent/CA2944049A1/en active Pending
- 2015-03-27 MX MX2016012403A patent/MX2016012403A/es unknown
- 2015-03-27 AU AU2015237275A patent/AU2015237275B2/en active Active
- 2015-03-27 IL IL248006A patent/IL248006B2/en unknown
- 2015-03-27 MA MA039708A patent/MA39708A/fr unknown
- 2015-03-27 EP EP22160342.6A patent/EP4159761A1/en active Pending
- 2015-03-27 WO PCT/US2015/023108 patent/WO2015148984A2/en not_active Ceased
- 2015-03-27 KR KR1020237022858A patent/KR102731863B1/ko active Active
- 2015-03-27 JP JP2017502946A patent/JP6598844B2/ja active Active
- 2015-03-27 KR KR1020167029997A patent/KR102553870B1/ko active Active
- 2015-03-27 TW TW104110160A patent/TWI694086B/zh active
-
2016
- 2016-09-27 CL CL2016002433A patent/CL2016002433A1/es unknown
-
2019
- 2019-01-25 US US16/257,511 patent/US11566069B2/en active Active
- 2019-03-27 CL CL2019000799A patent/CL2019000799A1/es unknown
-
2021
- 2021-10-08 CL CL2021002637A patent/CL2021002637A1/es unknown
-
2023
- 2023-01-27 US US18/160,745 patent/US20230348589A1/en not_active Abandoned
-
2024
- 2024-10-08 US US18/909,574 patent/US20250236669A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017512838A5 (show.php) | ||
| JP6681433B2 (ja) | Ｐ２ｘ７受容体アンタゴニスト及びアゴニスト | |
| RU2016141919A (ru) | Антитела, связывающиеся с человеческим каннабиноидным рецептором 1 (св1) | |
| AU2018312222B2 (en) | Anti-CD47 antibodies and uses thereof | |
| JP7273110B2 (ja) | 高親和性抗ｖｅｇｆ抗体 | |
| JP2018503380A5 (show.php) | ||
| JP2020501531A5 (show.php) | ||
| JP2017526370A5 (show.php) | ||
| JP2012501669A5 (show.php) | ||
| TW202144417A (zh) | Ｐｖｒｉｇ結合蛋白及其醫藥用途 | |
| JP2008516970A5 (show.php) | ||
| JP2012531922A5 (ja) | Ｔｏｌｌ様受容体２へのヒト化抗体またはその抗原結合部位 | |
| JP2012501670A5 (show.php) | ||
| JP2014500009A5 (show.php) | ||
| JP2013502913A5 (show.php) | ||
| JP2015530971A5 (show.php) | ||
| JP2010526028A5 (show.php) | ||
| JP2011207882A5 (show.php) | ||
| JP2015533853A5 (show.php) | ||
| JP2013538057A5 (show.php) | ||
| JP2011520898A5 (show.php) | ||
| JP2022507679A (ja) | Ｈｅｒ２／ｐｄ１二重特異性抗体 | |
| JP2014524733A5 (show.php) | ||
| WO2011094465A4 (en) | Methods of treating autoimmune diseases with dll4 antagonists | |
| US20240101675A1 (en) | Dual binding antibodies, methods of producing dual binding antibodies, and uses thereof |